Last mentioned: Mar 24, 2026
BIO-Europe Spring 2026
The conference commences, featuring Redwood AI's presentation to global industry leaders.
Pre-Conference Strategy
The company begins finalizing data sets and partnership objectives for the European market.
Selection Announced
Redwood AI Corp. officially announces its selection for the BIO-Europe Spring 2026 presentation.
Vancouver-based Redwood AI Corp. has been selected to present its machine learning capabilities at BIO-Europe Spring 2026, the continent's premier springtime biotechnology partnering event. The selection follows a competitive review process, signaling strong industry interest in Redwood's AI-driven approach to life sciences.
Redwood AI Corp. has been selected to present its AI-driven biotech solutions at BIO-Europe Spring 2026, the continent's premier springtime partnering event. This selection follows a rigorous competitive process and positions the Vancouver-based firm to engage with global pharmaceutical leaders and investors.
Redwood AI Corp. has been selected through a competitive process to present its AI-driven drug discovery platform at BIO-Europe Spring 2026. The event is Europe’s largest springtime biotech partnering conference, serving as a critical venue for securing global pharmaceutical collaborations.